Silicon Valley Capital Partners’s Bio-Techne TECH Stock Holding History

Silicon Valley Capital Partners’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-377	Closed	-$22.1K	–	327
2025 Q1	$22.1K	Hold	377	–	–	﹤0.01%	172
2024 Q4	$27.1K	Buy	377 +1	+0.3%	+$73	﹤0.01%	178
2024 Q3	$30.1K	Hold	376	–	–	﹤0.01%	163
2024 Q2	$26.9K	Buy	376 +1	+0.3%	+$74	﹤0.01%	170
2024 Q1	$26.4K	Hold	375	–	–	﹤0.01%	161
2023 Q4	$28.9K	Buy	+375	New	+$24.7K	﹤0.01%	147
2023 Q1	–	Hold	0	–	–	–	274
2022 Q4	–	Hold	0	–	–	–	236

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Silicon Valley Capital Partners's TECH Position: Q2 2025 in Review

Silicon Valley Capital Partners sold out of Bio-Techne (TECH) in Q2 2025, closing a stake of 377 shares — an estimated $22.1K sold.

Silicon Valley Capital Partners first reported a position in TECH in Q4 2023 and held it in 6 quarters. The position peaked at $30.1K in Q3 2024. 556 funds tracked by Wall St. Rank hold TECH as of Q2 2025.

Silicon Valley Capital Partners reported no remaining Bio-Techne position as of Q2 2025 after selling out during the quarter.
Silicon Valley Capital Partners sold 377 Bio-Techne shares in Q2 2025, an estimated $22.1K.
Silicon Valley Capital Partners first reported a position in Bio-Techne in Q4 2023 and held it in 6 quarters.
Silicon Valley Capital Partners's Bio-Techne position peaked at $30.1K in Q3 2024.
556 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2025.

Based on Silicon Valley Capital Partners's 13F filing for Q2 2025, filed 11 Sep 2025.